Pay in 4 interest-free payments of $200.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
developing therapeutic interventions
displaying multivalent α2-6 sialosides that are ligands for Siglecs and human-type influenza hemagglutinin
HCl / 414 / / Desacetyl Diltiazem-d6
Finastid-d9
enabling straightforward immobilization on chips
SI120080: Linagliptin-d4 label-new developing therapeutic interventionsC25H24D4N8O2 476. 54 Diabetes Type 2 Linagliptin d4 8 [(3R) 3 Amino 1 piperidinyl] 7 (2 butynyl) 3,7 dihydro 3 methyl 1 [(4 methyl 2 quinazolinyl)methyl] 1H purine 2,6 dione d4; BI 1356 d4; BI 1356BS d4; ONDERO d4
US$ 15.00
US$ 11.00
US$ 195.00
US$ 17.00
US$ 49.95
US$ 15.00
US$ 150.00
US$ 400.00
US$ 11.95
